Gene Expression Changes In Young and Geriatric Skin

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age21+
SponsorWright State University

About this trial

This study does not involve any particular diagnosis. The goal of this research study is to explore the effects of artificial sunlight (ultraviolet B radiation; UVB) on the skin of young adults versus geriatric adults. Sunlight exerts many effects on the body. There is evidence that in response to ultraviolet B radiation (UVB), which are the burning rays of sunlight, young adult skin responds differently than geriatric skin. In fact, researchers feel that this difference in how the skin reacts to UVB is why skin cancers are found in older skin. Researchers believe that a major difference between young adult and geriatric skin is that young skin has a lot of a protein called insulin-like growth factor-1 (IGF-1), whereas geriatric skin has very little. The current study will test how young adult versus geriatric skin responds to UVB, and if geriatric skin treated with an injection of small amount of IGF-1 drug will then act like young skin.

Eligibility criteria

Qualifiers

Male/Female

White skin (Fitzpatrick types I and II)

Age 21-30 or 65 and older

Able to comprehend procedures/risks

Disqualifiers

Known photosensitivity

Currently on photosensitizing medications

Diabetes Mellitus

History of abnormal scarring

Trial design

Treatments tested in this trial

  • Insulin-Like Growth Factor 1
  • No Insulin-Lie Growth Factor 1

Treatment groups

24 Participants
are divided into 2 treatment groups

Sponsors and collaborators